CRSP
Price
$41.86
Change
+$3.29 (+8.53%)
Updated
Jun 6 closing price
Capitalization
3.33B
64 days until earnings call
GLPG
Price
$27.73
Change
-$0.23 (-0.82%)
Updated
Jun 6 closing price
Capitalization
1.89B
45 days until earnings call
Interact to see
Advertisement

CRSP vs GLPG

Header iconCRSP vs GLPG Comparison
Open Charts CRSP vs GLPGBanner chart's image
CRISPR Therapeutics AG
Price$41.86
Change+$3.29 (+8.53%)
Volume$4.73M
Capitalization3.33B
Galapagos
Price$27.73
Change-$0.23 (-0.82%)
Volume$419.56K
Capitalization1.89B
CRSP vs GLPG Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. GLPG commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and GLPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CRSP: $37.22 vs. GLPG: $29.13)
Brand notoriety: CRSP and GLPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 76% vs. GLPG: 42%
Market capitalization -- CRSP: $3.33B vs. GLPG: $1.89B
CRSP [@Biotechnology] is valued at $3.33B. GLPG’s [@Biotechnology] market capitalization is $1.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileGLPG’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • GLPG’s FA Score: 0 green, 5 red.
According to our system of comparison, GLPG is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while GLPG’s TA Score has 6 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 3 bearish.
  • GLPG’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than GLPG.

Price Growth

CRSP (@Biotechnology) experienced а +0.64% price change this week, while GLPG (@Biotechnology) price change was +0.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

GLPG is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.33B) has a higher market cap than GLPG($1.89B). GLPG YTD gains are higher at: 5.927 vs. CRSP (-5.424). GLPG has higher annual earnings (EBITDA): -127.75M vs. CRSP (-447.31M). GLPG has more cash in the bank: 3.3B vs. CRSP (1.9B). GLPG has less debt than CRSP: GLPG (10.9M) vs CRSP (224M). GLPG has higher revenues than CRSP: GLPG (288M) vs CRSP (35M).
CRSPGLPGCRSP / GLPG
Capitalization3.33B1.89B177%
EBITDA-447.31M-127.75M350%
Gain YTD-5.4245.927-92%
P/E RatioN/A54.80-
Revenue35M288M12%
Total Cash1.9B3.3B58%
Total Debt224M10.9M2,055%
FUNDAMENTALS RATINGS
CRSP vs GLPG: Fundamental Ratings
CRSP
GLPG
OUTLOOK RATING
1..100
717
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
8147
P/E GROWTH RATING
1..100
7760
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (65) in the Biotechnology industry is in the same range as GLPG (75). This means that CRSP’s stock grew similarly to GLPG’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GLPG (100). This means that CRSP’s stock grew similarly to GLPG’s over the last 12 months.

GLPG's SMR Rating (92) in the Biotechnology industry is in the same range as CRSP (94). This means that GLPG’s stock grew similarly to CRSP’s over the last 12 months.

GLPG's Price Growth Rating (47) in the Biotechnology industry is somewhat better than the same rating for CRSP (81). This means that GLPG’s stock grew somewhat faster than CRSP’s over the last 12 months.

GLPG's P/E Growth Rating (60) in the Biotechnology industry is in the same range as CRSP (77). This means that GLPG’s stock grew similarly to CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPGLPG
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
82%
Momentum
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
56%
MACD
ODDS (%)
Bullish Trend 12 days ago
70%
Bullish Trend 12 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
53%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 12 days ago
60%
Declines
ODDS (%)
Bearish Trend 26 days ago
84%
Bearish Trend 28 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
83%
Bearish Trend 12 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
38%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.92%
RXRX - CRSP
72%
Closely correlated
+0.11%
BEAM - CRSP
72%
Closely correlated
-0.88%
NTLA - CRSP
69%
Closely correlated
+3.59%
ABCL - CRSP
62%
Loosely correlated
+3.03%
ALLO - CRSP
61%
Loosely correlated
+5.56%
More

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with RGNX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+0.55%
RGNX - GLPG
37%
Loosely correlated
-5.84%
BEAM - GLPG
37%
Loosely correlated
-0.88%
NTLA - GLPG
36%
Loosely correlated
+3.59%
CRSP - GLPG
34%
Loosely correlated
-0.92%
XNCR - GLPG
34%
Loosely correlated
-2.58%
More